Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population
Acute Coronary Syndrome/ Myocardial InfarctionCerebrovascular DiseaseCoronary Artery Disease+4 more
Principalinvestigator

Research Network

Collaboration Network

8 collaborators·28 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Joan Sayós Ortega, PhD MD

Hospital Universitario Valle de Hebron, Barcelona, Spain

Very Similar
1 trials

Shared therapeutic areas:

Acute Coronary Syndrome/ Myocardial InfarctionCerebrovascular DisordersCoronary Artery Disease+4 more

Worked with same sponsors:

Hospital Universitari Vall d'Hebron Research Institute
Collaborated on 1 trial
Similarity Score74%

Santiago Aguadé Bruix, PhD MD

Hospital Universitario Valle de Hebron, Barcelona, Spain

Very Similar
1 trials

Shared therapeutic areas:

Acute Coronary Syndrome/ Myocardial InfarctionCerebrovascular DisordersCoronary Artery Disease+4 more

Worked with same sponsors:

Hospital Universitari Vall d'Hebron Research Institute
Collaborated on 1 trial
Similarity Score74%

Joan Xavier Comella Carnicé, PhD MD

Hospital Universitario Valle de Hebron, Barcelona, Spain

Very Similar
1 trials

Shared therapeutic areas:

Acute Coronary Syndrome/ Myocardial InfarctionCerebrovascular DisordersCoronary Artery Disease+4 more

Worked with same sponsors:

Hospital Universitari Vall d'Hebron Research Institute
Collaborated on 1 trial
Similarity Score74%

Daniel Serón Micas, PhD MD

Hospital Universitario Valle de Hebron, Barcelona, Spain

Very Similar
1 trials

Shared therapeutic areas:

Acute Coronary Syndrome/ Myocardial InfarctionCerebrovascular DisordersCoronary Artery Disease+4 more

Worked with same sponsors:

Hospital Universitari Vall d'Hebron Research Institute
Collaborated on 1 trial
Similarity Score74%

Rafael Simó Canonge, PhD MD

Hospital Universitario Valle de Hebron, Barcelona, Spain

Very Similar
1 trials

Shared therapeutic areas:

Acute Coronary Syndrome/ Myocardial InfarctionCerebrovascular DisordersCoronary Artery Disease+4 more

Worked with same sponsors:

Hospital Universitari Vall d'Hebron Research Institute
Collaborated on 1 trial
Similarity Score74%

David García-Dorado Garcia, PhD MD

Hospital Universitario Valle de Hebron, Barcelona, Spain

Very Similar
1 trials

Shared therapeutic areas:

Acute Coronary Syndrome/ Myocardial InfarctionCerebrovascular DisordersCoronary Artery Disease+4 more

Worked with same sponsors:

Hospital Universitari Vall d'Hebron Research Institute
Collaborated on 1 trial
Similarity Score74%

Joan Genescà Ferrer, PhD MD

Hospital Universitario Valle de Hebron, Barcelona, Spain

Very Similar
1 trials

Shared therapeutic areas:

Acute Coronary Syndrome/ Myocardial InfarctionCerebrovascular DisordersCoronary Artery Disease+4 more

Worked with same sponsors:

Hospital Universitari Vall d'Hebron Research Institute
Collaborated on 1 trial
Similarity Score74%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score4%

Jiyan Chen, M.D.

Guangdong Provincial People's Hospital

Related
4 trials

Shared therapeutic areas:

Coronary Artery Disease
Similarity Score4%

Sonia Caprio, MD

Yale University

Related
9 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02248311PrincipalInvestigator

"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population

Acute Coronary Syndrome/ Myocardial InfarctionCerebrovascular DiseaseCoronary Artery Disease+4 more
Unknown

All 1 trials loaded